<SEC-DOCUMENT>0000950170-25-043975.txt : 20250324 <SEC-HEADER>0000950170-25-043975.hdr.sgml : 20250324 <ACCEPTANCE-DATETIME>20250324173509 ACCESSION NUMBER: 0000950170-25-043975 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250320 FILED AS OF DATE: 20250324 DATE AS OF CHANGE: 20250324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kulkarni Samarth CENTRAL INDEX KEY: 0001682019 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 25765222 MAIL ADDRESS: STREET 1: C/O CRISPR THERAPEUTICS AG STREET 2: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 </SEC-HEADER> <DOCUMENT> <TYPE>4 <SEQUENCE>1 <FILENAME>ownership.xml <DESCRIPTION>4 <TEXT> <XML> <?xml version="1.0"?> <ownershipDocument> <schemaVersion>X0508</schemaVersion> <documentType>4</documentType> <periodOfReport>2025-03-20</periodOfReport> <issuer> <issuerCik>0001674416</issuerCik> <issuerName>CRISPR Therapeutics AG</issuerName> <issuerTradingSymbol>CRSP</issuerTradingSymbol> </issuer> <reportingOwner> <reportingOwnerId> <rptOwnerCik>0001682019</rptOwnerCik> <rptOwnerName>Kulkarni Samarth</rptOwnerName> </reportingOwnerId> <reportingOwnerAddress> <rptOwnerStreet1>C/O CRISPR THERAPEUTICS</rptOwnerStreet1> <rptOwnerStreet2>105 WEST FIRST STREET</rptOwnerStreet2> <rptOwnerCity>BOSTON</rptOwnerCity> <rptOwnerState>MA</rptOwnerState> <rptOwnerZipCode>02127</rptOwnerZipCode> <rptOwnerStateDescription></rptOwnerStateDescription> </reportingOwnerAddress> <reportingOwnerRelationship> <isDirector>true</isDirector> <isOfficer>true</isOfficer> <isTenPercentOwner>false</isTenPercentOwner> <isOther>false</isOther> <officerTitle>Chief Executive Officer</officerTitle> </reportingOwnerRelationship> </reportingOwner> <aff10b5One>false</aff10b5One> <nonDerivativeTable> <nonDerivativeTransaction> <securityTitle> <value>Common Shares</value> </securityTitle> <transactionDate> <value>2025-03-20</value> </transactionDate> <transactionCoding> <transactionFormType>4</transactionFormType> <transactionCode>M</transactionCode> <equitySwapInvolved>false</equitySwapInvolved> </transactionCoding> <transactionAmounts> <transactionShares> <value>19688</value> </transactionShares> <transactionPricePerShare> <footnoteId id="F1"/> </transactionPricePerShare> <transactionAcquiredDisposedCode> <value>A</value> </transactionAcquiredDisposedCode> </transactionAmounts> <postTransactionAmounts> <sharesOwnedFollowingTransaction> <value>205116</value> </sharesOwnedFollowingTransaction> </postTransactionAmounts> <ownershipNature> <directOrIndirectOwnership> <value>D</value> </directOrIndirectOwnership> </ownershipNature> </nonDerivativeTransaction> <nonDerivativeTransaction> <securityTitle> <value>Common Shares</value> </securityTitle> <transactionDate> <value>2025-03-21</value> </transactionDate> <transactionCoding> <transactionFormType>4</transactionFormType> <transactionCode>S</transactionCode> <equitySwapInvolved>false</equitySwapInvolved> </transactionCoding> <transactionAmounts> <transactionShares> <value>10031</value> <footnoteId id="F2"/> </transactionShares> <transactionPricePerShare> <value>41.23</value> </transactionPricePerShare> <transactionAcquiredDisposedCode> <value>D</value> </transactionAcquiredDisposedCode> </transactionAmounts> <postTransactionAmounts> <sharesOwnedFollowingTransaction> <value>195085</value> </sharesOwnedFollowingTransaction> </postTransactionAmounts> <ownershipNature> <directOrIndirectOwnership> <value>D</value> </directOrIndirectOwnership> </ownershipNature> </nonDerivativeTransaction> <nonDerivativeHolding> <securityTitle> <value>Common Shares</value> </securityTitle> <postTransactionAmounts> <sharesOwnedFollowingTransaction> <value>85622</value> </sharesOwnedFollowingTransaction> </postTransactionAmounts> <ownershipNature> <directOrIndirectOwnership> <value>I</value> </directOrIndirectOwnership> <natureOfOwnership> <value>The Kulkarni 2023 GRAT</value> </natureOfOwnership> </ownershipNature> </nonDerivativeHolding> </nonDerivativeTable> <derivativeTable> <derivativeTransaction> <securityTitle> <value>Restricted Stock Units</value> </securityTitle> <conversionOrExercisePrice> <footnoteId id="F1"/> </conversionOrExercisePrice> <transactionDate> <value>2025-03-20</value> </transactionDate> <transactionCoding> <transactionFormType>4</transactionFormType> <transactionCode>M</transactionCode> <equitySwapInvolved>false</equitySwapInvolved> </transactionCoding> <transactionAmounts> <transactionShares> <value>19688</value> </transactionShares> <transactionPricePerShare> <footnoteId id="F1"/> </transactionPricePerShare> <transactionAcquiredDisposedCode> <value>D</value> </transactionAcquiredDisposedCode> </transactionAmounts> <exerciseDate> <footnoteId id="F3"/> </exerciseDate> <expirationDate> <footnoteId id="F3"/> </expirationDate> <underlyingSecurity> <underlyingSecurityTitle> <value>Common Shares</value> </underlyingSecurityTitle> <underlyingSecurityShares> <value>19688</value> </underlyingSecurityShares> </underlyingSecurity> <postTransactionAmounts> <sharesOwnedFollowingTransaction> <value>59062</value> </sharesOwnedFollowingTransaction> </postTransactionAmounts> <ownershipNature> <directOrIndirectOwnership> <value>D</value> </directOrIndirectOwnership> </ownershipNature> </derivativeTransaction> </derivativeTable> <footnotes> <footnote id="F1">Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.</footnote> <footnote id="F2">Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.</footnote> <footnote id="F3">This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.</footnote> </footnotes> <ownerSignature> <signatureName>Elizabeth Ryland Waldinger, attorney-in-fact</signatureName> <signatureDate>2025-03-24</signatureDate> </ownerSignature> </ownershipDocument> </XML> </TEXT> </DOCUMENT> </SEC-DOCUMENT>